ARG70361
SARS-CoV-2 Nucleocapsid recombinant protein (Omicron B1.1.529 Variant) (Tag Free)
SARS-CoV-2 Nucleocapsid recombinant protein (Omicron B1.1.529 Variant) (Tag Free) for SDS-PAGE
Overview
| Product Description | E. coli expressed, SARS-CoV-2 nucleocapsid recombinant protein (Omicron B1.1.529 Variant) |
|---|---|
| Tested Application | SDS-PAGE |
| Target Name | SARS-CoV-2 Nucleocapsid protein (Omicron) |
| Species | Virus |
| A.A. Sequence | Met1 - Ala416 |
| Expression System | E. coli |
Properties
| Form | Powder |
|---|---|
| Purity | >90% (by SDS-PAGE) |
| Buffer | PBS containing 0.5 M NaCl (pH 7.4) |
| Reconstitution | It is recommended to reconstitute the lyophilized protein in sterile water to a concentration not less than 200 μg/mL and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely. |
| Storage Instruction | For long term, lyophilized protein should be stored at -20°C or -80°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
| Highlight | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response |
|---|
